MCD vs TMO: Which Is the Better Buy?
Side-by-side comparison of McDonald's Corporation and Thermo Fisher Scientific Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-20.
McDonald's Corporation · Consumer Cyclical
$267.71
+20.6% upside to fair value
Med Conviction
Grade C+
High Quality
VS
Thermo Fisher Scientific Inc. · Healthcare
$464.61
+7.2% upside to fair value
Grade A
High Quality
QuantHub Verdict
MCD has more upside to fair value
(+20.6%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
MCD |
TMO |
| Current Price |
$267.71 |
$464.61 |
| Fair Value Estimate |
$322.85 |
$498.27 |
| Upside to Fair Value |
+20.6%
|
+7.2%
|
| Market Cap |
$190.2B |
$172.7B |
| Forward P/E |
—
|
25.2x
|
| EV / EBITDA |
16.4x
|
19.1x
|
| Price / Sales |
6.9x
|
3.8x
|
| Price / FCF |
27.0x
|
25.6x
|
| Revenue Growth YoY |
+9.4%
|
+6.2%
|
| Gross Margin |
57.4%
|
39.4%
|
| Operating Margin |
46.0%
|
17.8%
|
| Return on Equity |
-433.9%
|
13.3%
|
| Dividend Yield |
2.75% |
0% |
| FCF Yield |
3.7%
|
3.91%
|
| Analyst Consensus |
Buy
|
Strong Buy
|
Investment Thesis
McDonald's is a global quick-service restaurant franchisor and real-estate platform whose approximately 95% franchised restaurant base generates unusually high-margin, recurring royalty and rent income, supporting a 46.0% operating margin and 31.6% net margin. Business quality is high because its brand, global purchasing scale, nearly 29,000 drive-thrus, digital ecosystem and 210 million 90-day a…
Thermo Fisher Scientific is a leading healthcare company specializing in life science tools, diagnostics, and contract research and manufacturing services. It operates with a broad, multi-layered moat driven by scale, integration, and a long-tenured management team. The company exhibits solid fundamentals with a 13.3% ROE, 6.2% revenue growth, and 9.6% earnings growth in the most recent quarter. …
Accumulation Zones
| Metric |
MCD |
TMO |
| Zone Low |
$242.14 |
$373.70 |
| Zone High |
$274.42 |
$423.53 |
| In Buy Zone? |
Yes
|
No
|